OX04528 |
|||
| HY-161106 | MedChemExpress | Get quote | Ask for price |
|
Description: OX04528 (compound 68) is a potent, G-protein biased, and orally active GPR84 agonist. OX04528 no cytotoxicity. OX04528 inhibits cAMP production with an EC50 value of 0.00598 nM[1]. |
|||
OX04529 |
|||
| HY-161107 | MedChemExpress | Get quote | Ask for price |
|
Description: OX04529 (compound 69) is a potent, selective and orally active agonist of GPR84. OX04529 inhibits FSK-induced cAMP production with an EC50 of 0.0185 nM. OX04529 displayed excellent potency, high G-protein signaling bias[1]. |
|||
OX01914 |
|||
| T60594-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: OX01914 |
|||
OX01914 |
|||
| T60594-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: OX01914 |
|||
OX01914 |
|||
| T60594-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: OX01914 |
|||
OX01914 |
|||
| T60594-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: OX01914 |
|||
OX01914 |
|||
| T60594-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: OX01914 |
|||
CD134, Mouse (OX40)(OX-86), 1mg/mL |
|||
| BNUM2004-50 | Biotium | 1uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), 0.2mg/mL |
|||
| BNUB2004-100 | Biotium | 1uL | EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), 0.2mg/mL |
|||
| BNUB2004-500 | Biotium | 1uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), 1mg/mL |
|||
| BNUM3108-50 | Biotium | 1uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), 0.2mg/mL |
|||
| BNUB3108-100 | Biotium | 1uL | EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), 0.2mg/mL |
|||
| BNUB3108-500 | Biotium | 1uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
APC Anti-Mouse CD134 (OX40) (OX-86) |
|||
| MBS4165252-01mg | MyBiosource | 0.1mg | EUR 510 |
APC Anti-Mouse CD134 (OX40) (OX-86) |
|||
| MBS4165252-5x01mg | MyBiosource | 5x0.1mg | EUR 2040 |
OX40 Ligand/TNFSF4/OX40L |
|||
| E21-M74 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Mouse OX40 Ligand is produced by our Mammalian expression system and the target gene encoding Ser51-Leu198 is expressed with a 8His tag at the N-terminus. |
|||
OX40 Ligand/TNFSF4/OX40L |
|||
| MBS8533022-001mg | MyBiosource | 0.01mg | EUR 305 |
OX40 Ligand/TNFSF4/OX40L |
|||
| MBS8533022-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
Human OX40 Ligand,OX40L ELISA KIT |
|||
| JOT-EK3845Hu | Jotbody | 96 wells | Ask for price |
|
Description: Human |
|||
Human OX40 Ligand,OX40L ELISA KIT |
|||
| E3845Hu-1096T | Jiaxing Korain Biotech Ltd (BT Labs) | 10*96T | EUR 4122 |
Human OX40 Ligand,OX40L ELISA KIT |
|||
| E3845Hu-48wells | Jiaxing Korain Biotech Ltd (BT Labs) | 48 wells | EUR 300 |
Human OX40 Ligand,OX40L ELISA KIT |
|||
| E3845Hu-596T | Jiaxing Korain Biotech Ltd (BT Labs) | 5*96T | EUR 2061 |
Human OX40 Ligand,OX40L ELISA KIT |
|||
| E3845Hu-96wells | Jiaxing Korain Biotech Ltd (BT Labs) | 96 wells | EUR 458 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS167187-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3460 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS167187-48StripWells | MyBiosource | 48-Strip-Wells | EUR 285 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS167187-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1750 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS167187-96StripWells | MyBiosource | 96-Strip-Wells | EUR 425 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS3800183-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS3800183-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS3800183-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human OX40 Ligand (OX40L) ELISA Kit |
|||
| MBS3800183-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF568 conjugate, 0.1mg/mL |
|||
| BNC683108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF568 conjugate, 0.1mg/mL |
|||
| BNC683108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF594 conjugate, 0.1mg/mL |
|||
| BNC943108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF594 conjugate, 0.1mg/mL |
|||
| BNC943108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF647 conjugate, 0.1mg/mL |
|||
| BNC473108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF647 conjugate, 0.1mg/mL |
|||
| BNC473108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
PerCP-Cy5.5 Anti-Mouse CD134 (OX40) (OX-86) |
|||
| MBS4165603-01mg | MyBiosource | 0.1mg | EUR 625 |
PerCP-Cy5.5 Anti-Mouse CD134 (OX40) (OX-86) |
|||
| MBS4165603-5x01mg | MyBiosource | 5x0.1mg | EUR 2555 |
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF488A conjugate, 0.1mg/mL |
|||
| BNC883108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF488A conjugate, 0.1mg/mL |
|||
| BNC883108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), Biotin conjugate, 0.1mg/mL |
|||
| BNCB3108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), Biotin conjugate, 0.1mg/mL |
|||
| BNCB3108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF640R conjugate, 0.1mg/mL |
|||
| BNC403108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF640R conjugate, 0.1mg/mL |
|||
| BNC403108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF405S conjugate, 0.1mg/mL |
|||
| BNC043108-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF405S conjugate, 0.1mg/mL |
|||
| BNC043108-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Anti-Rat CD2/LFA-2/OX-34 Antibody (OX-34) |
|||
| MBS1569909-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Rat CD2/LFA-2/OX-34 Antibody (OX-34) |
|||
| MBS1569909-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
CD134, Mouse (OX40)(OX-86), CF568 conjugate, 0.1mg/mL |
|||
| BNC682004-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), CF568 conjugate, 0.1mg/mL |
|||
| BNC682004-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), CF594 conjugate, 0.1mg/mL |
|||
| BNC942004-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), CF594 conjugate, 0.1mg/mL |
|||
| BNC942004-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), CF647 conjugate, 0.1mg/mL |
|||
| BNC472004-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD134, Mouse (OX40)(OX-86), CF647 conjugate, 0.1mg/mL |
|||
| BNC472004-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||